ARCHIVES

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

This article is from The Cancer Letter archive.

Vol. 14 No. 02 | January 8, 1988

Download PDF Visit The Full Archive

Related Articles

Final Issue of ‘76

December 10, 1976

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

January 26, 2001

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

April 15, 1994

Oncology Nursing Society Names 15 To Advisory Panel.

September 29, 2000

In Brief: Cancer Control Needs More Oncologists, DCT recruiting for Prestigious Combines Job

November 21, 1975

Acupuncture Can Relieve Side Effects of Hormone Treatment

April 29, 2011